Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor
European Journal of Cancer · 2025-07 · 225 · 115565
DOI: 10.1016/j.ejca.2025.115565 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2025-07. Verfasst von Piotr Lukasz Rutkowski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electroni…. Hauptthemen laut MEDLINE: Axitinib, Gastrointestinal Stromal Tumors, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: piotr.rutkowski@nio.gov.pl.
- Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: anna.klimczak@nio.gov.pl.
- Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland; Digital Medicine Centre Maria Sklodowska-Curie National Research Institute of O…
- Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna 40138, Italy. Electronic address: maria.pantaleo@unibo.it.
- Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: tomasz.switaj@nio.gov.pl.
- Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland. Electronic address: pawel.rogala@nio.gov.pl.
Förderung
- Pfizer
Zitieren
APA
Rutkowski, P. L., Klimczak, A., Teterycz, P., Pantaleo, M. A., Switaj, T., Rogala, P., Poleszczuk, J., Nannini, M., Nigro, M. C., & Kozak, K. (2025). Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor. European Journal of Cancer, 225, 115565. https://doi.org/10.1016/j.ejca.2025.115565
Vancouver
Rutkowski PL, Klimczak A, Teterycz P, Pantaleo MA, Switaj T, Rogala P, et al. Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor. European Journal of Cancer. 2025;225:115565. doi:10.1016/j.ejca.2025.115565
BibTeX
@article{Rutkowski2025,
author = {Rutkowski, Piotr Lukasz and Klimczak, Anna and Teterycz, Pawel and Pantaleo, Maria Abbondanza and Switaj, Tomasz and Rogala, Pawel and Poleszczuk, Jan and Nannini, Margherita and Nigro, Maria Concetta and Kozak, Katarzyna},
title = {Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor},
journal = {European Journal of Cancer},
year = {2025},
volume = {225},
pages = {115565},
doi = {10.1016/j.ejca.2025.115565}
}
EUVIMED